VAXIMM Announces Presentations at ASCO 2019 and Other Upcoming Industry and Scientific Events

On April 18, 2019 VAXIMM AG, a Swiss/German biotech company focused on developing oral T-cell immunotherapies, reported that the Company will present an abstract about the design of its ongoing trial in patients with glioblastoma with VXM01 oral T-cell immunotherapy in combination with the anti-PD-L1 checkpoint inhibitor avelumab at the 2019 American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) Annual Meeting (Press release, Vaximm, APR 18, 2019, View Source [SID1234535195]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2019 ASCO (Free ASCO Whitepaper) (American Society of Clinical Oncology) Annual Meeting
May 31 – June 4, 2019
Chicago, IL, USA

The abstract (#269161) "Oral DNA vaccination targeting VEGFR-2 combined with anti-PD-L1 avelumab in patients with progressive glioblastoma, a phase I/II study: NCT03750071" will be presented during Poster Session: Central Nervous System Tumors, on June 2, 2019, 8:00 AM-11:00 AM CDT. The abstract will be available online on May 15, 2019 at 5 PM EDT at View Source

Additionally, the Company will participate in several other industry and scientific events in the second quarter of 2019.

European Neoantigen Summit
April 23 – 25, 2019
Amsterdam, The Netherlands

VAXIMM representatives will be available for one-on-one meetings during the summit. To schedule a meeting with VAXIMM, please contact [email protected].

Bio€quity Europe
May 20 – 21, 2019
Barcelona, Spain

Dr. Heinz Lubenau, Chief Operating Officer of VAXIMM, will give a corporate presentation. The Company will also host one-on-one meetings at this event. To request a meeting with VAXIMM, please sign up through the event’s meeting system.

17th CIMT (Free CIMT Whitepaper) (Association for Cancer Immunotherapy) Annual Meeting
May 21 – 23, 2019
Mainz, Germany
VAXIMM representatives will be available for one-on-one meetings during the event. To schedule a meeting with VAXIMM, please contact [email protected].